Preferred Label : Congenital disorder of glycosylation, type iid;
Symbol : CDG2D;
CISMeF acronym : CDG IID; CDG2D;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : CDGIId; Cdg iid;
Description : Congenital disorders of glycosylation (CDG), previously called carbohydrate-deficient
glycoprotein syndromes (CDGSs), are a group of hereditary multisystem disorders first
recognized by Jaeken et al. (1980). The characteristic biochemical abnormality of
CDGs is the hypoglycosylation of glycoproteins, which is routinely determined by isoelectric
focusing (IEF) of serum transferrin. Type I CDG comprises those disorders in which
there is a defect in the assembly of lipid-linked oligosaccharides or their transfer
onto nascent glycoproteins, whereas type II CDG comprises defects of trimming, elongation,
and processing of protein-bound glycans. For a general discussion of CDGs, see CDG1A
(212065).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the beta-1,4-galactosyltransferase gene (B4GALT1, 137060.0001).;
Laboratory abnormalities : Elevated creatine kinase; Prolonged activated partial prothrombin time (aPPT); Abnormal serum transferrin pattern by isoelectric focusing (hyposialylation);
Prefixed ID : #607091;
Origin ID : 607091;
UMLS CUI : C2931009;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)